Incyte Corp Stock - INCY Share Price Today, News and Discussion

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

2,094

Current Price	$85.60
Prev Close	$85.14
Open	$84.80
Dividend Yield	0.00%
50-Day Moving Average	$81.40
Beta	0.62
Avg. Volume	1.89M
PE Ratio	21.75

52-Week High	$86.29
52-Week Low	$65.07
Market Capitalization	$19.04B
EPS	$3.94
Price to Book	4.51
Revenue Per Employee	$1.59M
Enterprise Value/EBITDA	17.38

No INCY news at the moment.

INCY Incyte Corp.

About

Feed

Fundamentals

News